TXP Medical
TXP Medical develops a physician-led medical data platform for emergency, ICU, prehospital, and clinical research use in Japan, selling subscription software to 100+ hospitals, 51 municipalities, and pharmaceutical clients through direct enterprise sales.
- Company typePrivate
- Founded2017
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What TXP Medical does
TXP Medical Co., Ltd. is a Japanese health-IT company founded in August 2017 by emergency physician Dr. Tomohiro Sonoh to address fragmentation of medical data across Japanese emergency, intensive-care, and prehospital care settings. The company develops and sells a platform-plus-modules suite anchored on NEXT Stage ER, an emergency-department information system used in over 100 major hospitals and approximately 50% of Japan's university hospitals and emergency medical centres. Adjacent modules cover ICU patient management (NEXT Stage ICU), doctor car and helicopter registries, inter-hospital transfer coordination (NEXT Stage CONNECT), oncology databases, dialysis DX, and AI-powered medical documentation (NEXT Stage Document Assistant and SpeechER). On the prehospital side, NSER mobile is deployed across 51 municipalities covering 12 million people, digitising communication between fire departments and hospitals. Custom electronic data capture (EDC) systems and a medical data warehouse spanning 50 large hospitals and 38 million+ electronic medical records support clinical research and pharmaceutical real-world data services.
The company monetises primarily through annual subscription and license fees for hospital and municipality software, custom EDC construction services for academic and pharmaceutical research clients, and professional services for system integration and pharmaceutical RWD studies. Customers include university hospitals (Hokkaido University, Kagoshima City Hospital, Kameda General, Nara Medical University), national centres (National Center for Child Health and Development), municipalities (Sendai, Kobe, Eniwa), and pharmaceutical companies (Tanabe Pharmaceutical). Sales is direct enterprise sales supported by academic conference presence, government innovation programmes (SBIR, SIP, AMED), and an in-house physician-led research team. TXP Medical holds ten granted patents, ISO 27001/27017/27018/9001 certifications, and has raised approximately $18.4M in venture funding across rounds led by UTEC and MPower Partners. The management team includes 10 full-time physicians and board representation from UTEC and Itochu Corporation, and the company transitioned to AI-native operations in January 2026 by deploying Claude company-wide.
TXP Medical firmographics
Firmographics- Name
- TXP Medical
- Legal name
- TXP Medical株式会社 (TXP Medical Co. Ltd.)
- Website
- https://txpmedical.jp
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TXP Medical develops a physician-led medical data platform for emergency, ICU, prehospital, and clinical research use in Japan, selling subscription software to 100+ hospitals, 51 municipalities, and pharmaceutical clients through direct enterprise sales.
- Ownership category
- akta.pro rank
TXP Medical industry classification
Industry- Product category
- Healthcare Clinical Workflow Software
- NAICS
- Software Publishers (5132), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Emergency Department (ED) Information Systems & Documentation (HLACAAAE)
- akta.pro secondary industries
- Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ), Healthcare Master Data Management (MDM) & Patient/Provider Identity Data (HLACAIAB)
Keywords
Where TXP Medical is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
TXP Medical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hospital Emergency/ICU Software (NEXT Stage ER, ICU, Dr.Car/Heli, CONNECT, Oncology, Dialysis DX): Annual subscription/license fees for hospital emergency and ICU management systems. Multiple product tiers including core ER platform, ICU dashboard, doctor car/heli registry, hospital transfer coordination, oncology database, and dialysis DX tools. Sold directly to large hospitals.
- Municipality Emergency Medical Information System (NSER Mobile): Subscription-based emergency medical information system for fire departments and municipal governments. Covers real-time emergency transport information sharing between emergency teams and hospitals.
- EDC (Electronic Data Capture) Construction and Operation Services: Custom EDC system design, construction, and ongoing operational support for clinical research. Physician-led EDC design combined with FileMaker development. Services include study design support, data management, statistical analysis, and publication support.
- NEXT Stage Document Assistant (NSDA): AI-powered medical document creation system. Available in both on-premises and cloud deployment. Generates discharge summaries, referral letters, and other medical documents.
- Pharmaceutical RWD Services (Medical Data Services): Real-world data (RWD) services for pharmaceutical companies including retrospective studies, prospective observational studies, registry construction and management, and data analysis. Supported by medical data warehouse with 38M+ EMR records and physician-led research team.
- System Integration and Interoperability Services: Cross-vendor system integration services connecting NSER mobile with fire department statistical systems (e.g., ベストル119), hospital EMR systems, and government health data platforms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Contact sales for all products |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels10 records
TXP Medical product offering
Product offeringCore offering
TXP Medical develops and sells a suite of medical data software platforms that automate patient documentation, triage, vital sign capture, AI-powered medical document creation, and registry data collection for emergency departments, ICUs, EMS/ambulance services, and clinical research. Its NEXT Stage ER platform anchors a modular family that extends into ICU dashboards, doctor car/helicopter record systems, inter-hospital transfer coordination, oncology databases, dialysis documentation, voice-input medical records, and custom EDC construction. The company also offers real-world data (RWD) services to pharmaceutical companies, leveraging an integrated data warehouse covering 50 large hospitals and over 38 million electronic medical records.
Product overview
TXP Medical offers a platform-plus-modules product architecture centered on emergency and acute care digitalization. The core NEXT Stage ER platform provides emergency department information management with integrated patient records, triage, and research data collection, which extends into specialized modules including NEXT Stage ICU for intensive care, NEXT Stage Dr.Car/Dr.Heli for prehospital transport, NEXT Stage CONNECT for hospital transfer coordination, and NSER mobile for EMS field operations. Additional modules address specific clinical domains: 透析DX for dialysis documentation, NEXT Stage Document Assistant and SpeechER for AI-powered medical documentation and voice input, and NEXT Stage Oncology for cancer registry databases. The EDC construction service provides custom clinical research database development using FileMaker, while TXP Research conducts academic clinical studies using accumulated product data.
Differentiator
Problem solved
Functional benefit
Brands
- NEXT Stage ER: Emergency department system for large hospital emergency outpatient care, providing efficient patient information recording, staff information sharing, and research data accumulation. Holds dominant market share in emergency center-class hospitals.
- NEXT Stage ICU
- NEXT Stage Dr.Car/Dr.Heli
- NSER mobile
- SpeechER
- NEXT Stage Document Assistant
- NEXT Stage CONNECT
- NEXT Stage Oncology
- EDC構築運用サービス
- 透析DX
- NEXT Stage EDC
- TXP Research
- ER Collection
- EMS Collection
- TXP CLUB
- Medical Data Lab
Products and services
- NEXT Stage ER Emergency department information system for large hospitals (救命センタークラス). Integrates patient records, staff information sharing, and research data accumulation. Features disease-specific templates, automatic JTAS/qSOFA/NEWS triage scoring, real-time vital sign capture, AI-powered registry auto-registration with 90%+ accuracy, and integration with doctor car/EMS/hospital transfer systems. Deployed in over 100 major hospitals with approximately 50% market share in university hospitals and emergency medical centers.
- NEXT Stage ICU ICU patient dashboard that aggregates vital signs, laboratory data, and severity scores (SOFA, APACHE) with organ-specific assessments. Enables clinical research data collection and multi-facility registry data export, and integrates with NEXT Stage ER for unified ER-to-ICU patient management. Used by institutions including Hokkaido University Hospital.
- NEXT Stage Dr.Car/Dr.Heli Mobile platform for doctor car and helicopter emergency medical record input with registry integration. Supports offline data entry with automatic synchronization, enabling post-flight verification and quality improvement for emergency transport services. At Kagoshima City Hospital, record creation time was reduced from ~93.5 minutes to ~41 minutes per case, with ~65% reduction in clerk workload.
- NEXT Stage CONNECT
- Dialysis DX (透析DX) Dialysis digital transformation system using mobile OCR to extract vital sign and dialysis data from monitors via smartphone camera, reducing double data entry burden and improving clinical documentation efficiency for dialysis clinics such as Akiota Hospital.
- NEXT Stage Document Assistant (NSDA) Generative AI system that automatically creates medical documents (discharge summaries, referral letters, medical certificates) from electronic medical record data. Uses proprietary physician algorithms to control AI output quality and prevent hallucinations. Available in both on-premises and cloud deployment; Kameda General Hospital achieved 100% documentation completeness with local LLM on-premises deployment.
- SpeechER Generative AI-powered voice-input medical record application that converts natural clinician speech into formatted EMR entries. Includes OCR for documents and vital sign monitors, with QR code output for EMR integration. Reports up to 70% reduction in medical record documentation time.
- NSER mobile Emergency medical information system for EMS/ambulance services enabling field data entry, OCR capture of patient documents, generative AI voice input, real-time hospital communication, and automated statistical reporting integration with systems like Bestru 119. Covers over 12 million people across 51 municipalities; reduces emergency report creation time by up to 80% and hospital contact time by 22%.
- EDC Construction and Operation Service Electronic Data Capture (EDC) system construction and operation service led by physician researchers. Uses FileMaker platform to build custom EDC systems with OCR capabilities, smartphone support, automated registry export, block/stratified/minimization randomization, and flexible design changes for clinical studies. Over 40 academic research registry/EDC builds completed.
- NEXT Stage Oncology Oncology database system that elevates department-specific databases (physician databases) with data warehouse integration, structured data support, and clinical research functionality for cancer treatment centers.
- NEXT Stage EDC Next-generation Electronic Data Capture system utilizing generative AI to extract and analyze unstructured medical record data, enabling faster study setup and richer data capture than legacy EDC platforms.
Quantifiable outcome
- Medical record documentation time reduced by up to 70%
- +7 more outcomes
Companies that use TXP Medical
Customer profileNamed customers15 records
Segments5 records
Ideal customer profiles4 records
TXP Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability12 records
Feature7 records
TXP Medical partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered strategic and core.
- Tanabe Pharmaceutical Co., Ltd. (田辺ファーマ株式会社)strategicTXP Medical supports Tanabe Pharmaceutical's 4SigHT study — a 6-year prospective observational study of IgG4-related disease drug (inebilizumab) with ~40 participating institutions and ~100 patients. TXP Medical provides EDC, data warehouse, and study operations support.
- Nagasaki University and Yokohama City UniversitystrategicResearch collaboration starting March 2026 for dyspnea management study using generative AI-powered NEXT Stage EDC. Nagasaki University and Yokohama City University collaborate with TXP Medical on AI-EDC for extracting and analyzing unstructured medical record data in primary care.
- Nara Medical University Hospital (奈良県立医科大学附属病院)strategicCollaborative development of N-STARS (Nara Stroke Tracking & Registry System) — a stroke patient EDC system for long-term follow-up across acute, recovery, and maintenance phases in Nara Prefecture. Collaboration involves Nara Medical University Hospital and Nara Prefecture.
- Apple Japan, Inc. / Claris (Claris FileMaker公式リセラーパートナー)coreApple Japan is a listed partnership company, specifically as a Claris FileMaker authorized reseller partner. TXP Medical develops its NEXT Stage ER and EDC systems on the FileMaker/Claris platform and holds official reseller status.
- Eniw City Fire Department (恵庭市消防本部)strategicEniw City Fire Department implemented NSER mobile and established cross-vendor integration with Bestru 119 fire department statistical system. This cross-vendor integration (NSER mobile × Bestru 119) represents an innovative interoperability model achieving 570 hours annual efficiency.
- Medical device company ( название не раскрыто)strategicCollaborative research on cerebral aneurysm treatment (craniotomy clipping vs endovascular treatment) using DPC data and electronic medical records from 2 large domestic university hospitals, analyzing 345 cases.
Scale indicators16 records
Recent moves6 records
Expansion highlights6 records
TXP Medical competitors and assessment
Company assessmentEmerging players
- Suki AI: AI-powered voice-enabled clinical documentation assistant for ambulatory and acute settings — directly comparable to TXP's SpeechER generative-AI voice-input product category.
- Abridge: Generative AI medical conversation and documentation platform competing in the same ambient-AI clinical scribe category as SpeechER and NEXT Stage Document Assistant.
Broad incumbents
- Nihon Kohden: Leading Japanese patient monitoring and medical electronics company with ICU/emergency department systems and EMR integrations that compete with TXP's acute-care platform modules.
- Philips Healthcare: Global incumbent offering ICU patient monitoring, clinical decision support, and acute-care IT solutions that overlap with TXP's NEXT Stage ICU and broader hospital IT positioning.
- JMDC: Japan's largest commercial health data analytics company serving insurers, pharma, and providers with claims and health checkup databases — broader incumbent in the same RWD/medical data services category.
Regional players
- Cyto (Epsilon): Japanese pharma-focused real-world data and clinical research services provider — comparable in pharma RWD/registry services but concentrated in oncology commercial data rather than acute-care EMR-based RWD.
Direct peers
- HOKUTO: Japanese healthtech platform providing clinical decision support and medical content for physicians, with overlap in physician-targeted workflow tools serving emergency and acute-care settings.
- Medical Data Vision: Japanese RWD and DPC data platform serving pharma, hospitals, and academia — directly competes with TXP's Medical Data Warehouse and pharmaceutical RWD services, and is also an investor in TXP.
- T-ICU: Japanese telemedicine and ICU remote monitoring specialist — competing with TXP's NEXT Stage ICU in providing ICU workflow and intensivist-support technology to Japanese hospitals.
Others
- Claris International: Apple-owned FileMaker platform provider on which TXP's NEXT Stage ER and EDC systems are built — a key technology/infrastructure enabler and reseller partner for TXP.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
TXP Medical social profiles
Digital presenceTXP Medical compliance and trust
Trust signalCompliance4 records
TXP Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
TXP Medical leadership team
Management profileNumber of profiles
Profiles11 records
TXP Medical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TXP Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TXP Medical
What does TXP Medical do?
TXP Medical develops and sells a suite of medical data software platforms that automate patient documentation, triage, vital sign capture, AI-powered medical document creation, and registry data collection for emergency departments, ICUs, EMS/ambulance services, and clinical research. Its NEXT Stage ER platform anchors a modular family that extends into ICU dashboards, doctor car/helicopter record systems, inter-hospital transfer coordination, oncology databases, dialysis documentation, voice-input medical records, and custom EDC construction. The company also offers real-world data (RWD) services to pharmaceutical companies, leveraging an integrated data warehouse covering 50 large hospitals and over 38 million electronic medical records.
Is TXP Medical a public or private company?
TXP Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was TXP Medical founded?
TXP Medical was founded in 2017. It employs 11 to 50 people.
Where is TXP Medical based?
TXP Medical is headquartered in Tokyo, Japan, in the Asia region.
How does TXP Medical make money?
Six revenue lines are on record. Hospital Emergency/ICU Software (NEXT Stage ER, ICU, Dr.Car/Heli, CONNECT, Oncology, Dialysis DX) is the primary driver. The others are municipality Emergency Medical Information System (NSER Mobile), EDC (Electronic Data Capture) Construction and Operation Services, NEXT Stage Document Assistant (NSDA), pharmaceutical RWD Services (Medical Data Services) and system Integration and Interoperability Services.
Who are TXP Medical's main competitors?
Emerging players on record are Suki AI and Abridge. Broad incumbents are Nihon Kohden, Philips Healthcare and JMDC. Cyto (Epsilon) is listed as a regional player. Direct peers are HOKUTO, Medical Data Vision and T-ICU. Claris International is listed as an others.
Does TXP Medical have an API?
No public API is recorded for TXP Medical.
What industry is TXP Medical in?
TXP Medical's product category is Healthcare Clinical Workflow Software. Its primary akta.pro industry code is HLACAAAE, Emergency Department (ED) Information Systems & Documentation, with a secondary code of HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation. Its NAICS code is 5132 and its SIC code is 8000.